Hepatitis B virus-associated hepatocellular carcinoma from India: Role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes

被引:7
|
作者
Vivekanandan P. [1 ]
Torbenson M. [1 ]
Ramakrishna B. [2 ]
机构
[1] Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
[2] Department of Pathology, Christian Medical College, Vellore
基金
美国国家卫生研究院;
关键词
Beta-catenin; FFPE; HBV genotypes; HCC; TP53;
D O I
10.1007/s12029-010-9222-4
中图分类号
学科分类号
摘要
Purpose: Chronic hepatitis B virus (HBV) infection is the major risk factor for hepatocellular carcinoma (HCC) in India. Studies from other countries have linked HBV genotype C to a higher risk for HCC. This study was carried out to determine the association between genotype and HCC and also the frequency of mutations in CTNNB1 (beta-catenin) and TP53 genes in HBV-related HCC. Methods: Formalin-fixed paraffin-embedded (FFPE) tissues from 20 (15 autopsy, five resected specimens) cases of HBV-associated HCC were examined. Viral genotype was determined by sequencing portions of the HBV S gene using four overlapping PCR amplicons. Exon 3 of CTNNB1 and exon 7 of TP53 were sequenced. Results: HBV genotyping was possible in 14 of 20 cases; genotype D was most common (n=11) followed by C (n=2) and A (n=1). CTNNB1 mutations were noted in two of 15 amplifiable cases while two of 10 specimens showed TP53 mutations. Conclusions: HBV genotype can be ascertained from FFPE sections by sequencing multiple overlapping fragments to avoid the limitation of fragmented DNA. Genotype D was the common genotype in HBV-associated HCC. The very low frequency of TP53 mutation suggests low levels of aflatoxin B1 exposure. The beta-catenin pathway appears not to be significantly involved in HBV-related HCC in India. However, further larger studies are required to confirm these findings. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码:20 / 25
页数:5
相关论文
共 29 条
  • [1] Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections
    Tornesello, Maria Lina
    Buonaguro, Luigi
    Tatangelo, Fabiana
    Botti, Gerardo
    Izzo, Francesco
    Buonaguro, Franco M.
    GENOMICS, 2013, 102 (02) : 74 - 83
  • [2] Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection
    Saitta, Carlo
    Lanza, Marika
    Bertuccio, Antonio
    Lazzara, Salvatore
    Navarra, Giuseppe
    Raimondo, Giovanni
    Pollicino, Teresa
    CANCER GENETICS, 2015, 208 (10) : 513 - 516
  • [3] Frequency of TP53, CTNNB1, and TERT promoter mutations in patients with hepatocellular carcinoma
    Lombardo, D.
    Saitta, C.
    Giosa, D.
    di Tocco, F. Casuscelli
    Musolino, C.
    Caminiti, G.
    Chines, Valeria
    Franze, M. S.
    Navarra, G.
    Raimondo, G.
    Pollicino, T.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E52 - E53
  • [4] Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma
    Kumar, Sonu
    Nadda, Neeti
    Quadri, Afnan
    Kumar, Rahul
    Paul, Shashi
    Tanwar, Pranay
    Gamanagatti, Shivanand
    Dash, Nihar Ranjan
    Saraya, Anoop
    Nayak, Baibaswata
    FRONTIERS IN GENETICS, 2023, 14
  • [5] Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy
    Lombardo, Daniele
    Saitta, Carlo
    Giosa, Domenico
    Di Tocco, Francesca Casuscelli
    Musolino, Cristina
    Caminiti, Giuseppe
    Chines, Valeria
    Franze, Maria Stella
    Alibrandi, Angela
    Navarra, Giuseppe
    Raimondo, Giovanni
    Pollicino, Teresa
    ONCOLOGY LETTERS, 2020, 19 (03) : 2368 - 2374
  • [6] Frequency of TP53, CTNNB1, and TERT promoter mutations in patients with hepatocellular carcinoma from Southern Italy
    Lombardo, Daniele
    Saitta, Carlo
    Musolino, Cristina
    Navarra, Giuseppe
    Raimondo, Giovanni
    Pollicino, Teresa
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E840 - E840
  • [7] FREQUENCY OF TP53, CTNNB1, AND TERT PROMOTER MUTATIONS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA FROM SOUTHERN ITALY
    Lombardo, Daniele
    Saitta, Carlo
    Giosa, Domenico
    Musolino, Cristina
    Caminiti, Giuseppe
    Navarra, Giuseppe
    Raimondo, Giovanni
    Pollicino, Teresa
    HEPATOLOGY, 2019, 70 : 1149A - 1149A
  • [8] Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection
    Davod Javanmard
    Mohammad Najafi
    Mohammad Reza Babaei
    Mohammad Hadi Karbalaie Niya
    Maryam Esghaei
    Mahshid Panahi
    Fahimeh Safarnezhad Tameshkel
    Ahmad Tavakoli
    Seyed Mohammad Jazayeri
    Hadi Ghaffari
    Angila Ataei-Pirkooh
    Seyed Hamidreaz Monavari
    Farah Bokharaei-Salim
    Infectious Agents and Cancer, 15
  • [9] Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection
    Javanmard, Davod
    Najafi, Mohammad
    Babaei, Mohammad Reza
    Niya, Mohammad Hadi Karbalaie
    Esghaei, Maryam
    Panahi, Mahshid
    Tameshkel, Fahimeh Safarnezhad
    Tavakoli, Ahmad
    Jazayeri, Seyed Mohammad
    Ghaffari, Hadi
    Ataei-Pirkooh, Angila
    Monavari, Seyed Hamidreaz
    Bokharaei-Salim, Farah
    INFECTIOUS AGENTS AND CANCER, 2020, 15 (01)
  • [10] Hepatitis B virus-associated hepatocellular carcinoma: Study from Central India
    Chaudhary, Satyarth
    Thakur, Bhagwan Singh
    Jain, Sunil
    Jain, Neeraj
    Kumar, Ravindra
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 347 - 347